Craig Kevin James 4

What Happened Craig Kevin James, Chief Medical Officer of AtaiBeckley Inc. (ATAI), exercised stock options on April 20, 2026 to acquire a total of 42,579 shares (27,280 shares at $1.50 and 15,299 shares at $1.84) for aggregate exercise cost of $69,070. The same day he sold 42,579 shares in an open-market or private sale at $5.00 per share, generating proceeds of $212,895. The Form 4 also records the derivative option instruments being converted/disposed in connection with the exercises (reported with $0 cash consideration).

Key Details

• Transaction date: April 20, 2026 (Form filed April 22, 2026 — timely)
• Option exercises acquired: 27,280 shares @ $1.50 ($40,920); 15,299 shares @ $1.84 ($28,150). Total shares acquired: 42,579; total cost: $69,070.
• Sale: 42,579 shares sold @ $5.00 for $212,895.
• Footnotes: Trades executed under a Rule 10b5-1 trading plan adopted Dec 19, 2025 (F1). Two option grants have staged vesting schedules (F2, F3: 25% vested on Jan 1, 2026 and Jan 1, 2025 respectively, remainder in 36 monthly installments).
• Shares owned after the transactions: not specified in the provided filing details.

Context

• Because the exercises and sale occurred the same day, this functions like a cashless exercise (options converted to shares and those shares sold immediately). Such transactions are commonly executed under pre-established 10b5-1 plans and are typically routine liquidity events rather than a direct buy/sell signal about company prospects.
• Transaction codes: M = option exercise/conversion, S = sale. The filing does not indicate any late reporting.